MedicaidAdministrativeHigh impact
Newsletter Vol 33, No.16
New Jersey Medicaid·NJ·Pharmacy
We identified it
Jun 20, 2026
Summary
New Jersey Medicaid/NJ Family Care now requires providers to check the New Jersey Prescription Monitoring Program (NJPMP) database before prescribing or dispensing controlled dangerous substances to comply with the SUPPORT Act. This is a mandatory compliance requirement for all controlled substance prescriptions.
Action Required
Immediately: All prescribing providers must access and check the New Jersey Prescription Monitoring Program (NJPMP) database before prescribing any controlled dangerous substances to Medicaid/NJ Family Care members. Clinical staff should update workflow protocols to include NJPMP checks as a mandatory step. Document NJPMP consultation in patient records. Failure to comply with SUPPORT Act requirements may result in regulatory violations and claim issues.